Adult Dose of Hepatitis B Vaccine Begins at Age 20
The adult dose of hepatitis B vaccine should be given starting at age 20 years. 1
Age-Based Dosing Algorithm
According to the 2022 ACIP guidelines, hepatitis B vaccine dosing is stratified by specific age cutoffs 1:
For Recombivax HB:
- Ages 11-15 years: 10 mcg (0.5 mL volume) - pediatric dose
- Ages 16-19 years: 10 mcg (1.0 mL volume) - transitional dosing
- Age ≥20 years: 10 mcg (1.0 mL volume) - adult dose
For Engerix-B:
- Ages 11-19 years: 10 mcg (0.5 mL volume) - pediatric dose
- Age ≥20 years: 20 mcg (1.0 mL volume) - adult dose
For Heplisav-B, Twinrix, and PreHevbrio:
- Age ≥18 years: Adult formulation and dosing
Key Clinical Considerations
The critical transition point is age 20 for the two most commonly used vaccines (Recombivax HB and Engerix-B). 1, 2 This represents a clear demarcation where both the dose concentration and volume change to adult formulations.
Important Pitfall to Avoid:
For adolescents aged 11-15 years receiving the 2-dose Recombivax HB schedule: if they turn 16 years old before receiving their second dose, you must switch them to a 3-dose series using the pediatric formulation rather than continuing with the adult 2-dose schedule 1. This is a commonly missed detail that can lead to inadequate immunization.
Special Populations:
- Immunocompromised adults and hemodialysis patients ≥20 years: Require higher doses (40 mcg for both Recombivax HB and Engerix-B) 1
- Pregnant women: Should receive Engerix-B, Recombivax HB, or Twinrix (not Heplisav-B or PreHevbrio due to insufficient safety data) 1
The 2022 ACIP guidelines now recommend universal hepatitis B vaccination for all adults aged 19-59 years, eliminating the need for risk-based screening 1. This expanded recommendation aims to increase vaccination coverage and reduce hepatitis B transmission, supporting the goal of eliminating hepatitis B in the United States by 2030 3.